Ramakant Vempati

Contributor

Data analyst and former Goldman Sachs executive, Ramakant Vempati is the co-founder of 2022 FDA breakthrough device Wysa, an AI-based digital companion for behavioral health.

Biotech & Health

How to obtain FDA buy-in and unlock more funding for your health tech startup

Ramakant Vempati

7:00 am PST • November 23, 2022

There are many regulatory organizations that offer credibility and validation to incoming healthcare solutions, but the FDA is the best place to start.